Skip to main content
Defiance International

Critical role of PepT1 in promoting colitis-associated cancer and therapeutic benefits of the anti-inflammatory PepT1-mediated tripeptide KPV in a murine model.

In vivo/preclinical record. Cellular and molecular gastroenterology and hepatology, 2016.

  • Animal
  • 2016

Authorship

Exact sentences from the abstract. No machine-written text is on this page. No person reviewed it.

Source: the abstract of PMID 27458604. Checked Verification: Evidence verified by machine against declared source

This study and its findings belong to the authors cited. Defiance International, a supplier of chemical sequences for research use, keeps this record and makes no claim from its findings.

Verify a lot

Evidence verified by machine against declared source

Open declared source

Key facts

Design
Not reported
System
Animal
Scale
Not published. Nothing is shown here and nothing is substituted for it.
Comparator
None reported
Journal
Cellular and molecular gastroenterology and hepatology
Year
2016
PMID
27458604
Verification
Evidence verified by machine against declared source The stored extraction was checked against its declared source. Public summary availability is separate. No tier is an endorsement, an evidence-strength rating, or independent replication, and none establishes efficacy, safety, or suitability.
Full-text availability
Abstract only

Technical summary

Participants or experimental system

Mice with hPepT1 overexpression in intestinal epithelial cells (transgenic [TG]) or PepT1 (PepT1-knockout [KO]) deletion were used and CAC was induced by azoxymethane/dextran sodium sulfate.

Not reported in the declared source: Methods, Key findings. Not published in this record: Research question, Study design, Study scale, Intervention or exposure, Comparator, Outcomes examined, Key findings.

Limitations and uncertainty

Not published. Nothing is shown here and nothing is substituted for it.

Cite

Cite the study

Critical role of PepT1 in promoting colitis-associated cancer and therapeutic benefits of the anti-inflammatory PepT1-mediated tripeptide KPV in a murine model.
Viennois E, Ingersoll SA, Ayyadurai S et al. Cellular and molecular gastroenterology and hepatology. 2016. PMID 27458604. DOI 10.1016/j.jcmgh.2016.01.006

The study and its abstract belong to their authors and publisher. Cite them for anything the study found.

Report an error

If a sentence on this record does not match the abstract, tell us which one. A report starts an automatic re-check by machine. No person reads the record first.

The form takes a sentence and your note. It asks for no name and no address, and we store neither. Do not put personal details in the note.

The report form runs in the interactive page. Open this record with scripts enabled to send a report.

Corrections on this record

No correction has been recorded for this record.

Method sheet

No machine-drafted summary is published on this record. Any section shown is the abstract’s own sentence, printed as issued.